Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.57 |
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 3/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.52 |
| ▸ | MGAM | O43451 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | SI | P14410 | 1/20 | 0.50 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.50 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | GABBR2 | O75899 | 3/20 | 0.47 |
| ▸ | GABBR1 | Q9UBS5 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12158732 | 1.00 | L3MBTL1 (0.57) | L3MBTL1ATMPOLBCYP2C9CYP2C19 | |
| SCHEMBL28731474 | 0.90 | L3MBTL1 (0.64) | L3MBTL1ATMPOLBCYP2C9CYP2C19 | |
| SCHEMBL12158645 | 0.89 | ATM (0.66) | L3MBTL1ATMPOLBCYP2C9CYP2C19 | |
| SCHEMBL28114650 | 0.89 | ATM (0.66) | L3MBTL1ATMPOLBCYP2C9CYP2C19 | |
| SCHEMBL2581702 | 0.89 | ATM (0.66) | L3MBTL1ATMPOLBCYP2C9CYP2C19 | |
| SCHEMBL28010708 | 0.86 | L3MBTL1 (0.59) | L3MBTL1ATMPOLBMGAMGAA | |
| SCHEMBL2579321 | 0.86 | L3MBTL1 (0.59) | L3MBTL1ATMPOLBMGAMGAA | |
| SCHEMBL12158725 | 0.86 | L3MBTL1 (0.59) | L3MBTL1ATMPOLBMGAMGAA | |
| SCHEMBL12158733 | 0.84 | L3MBTL1 (0.57) | L3MBTL1ATMPOLBMGAMGAA | |
| SCHEMBL2584297 | 0.84 | L3MBTL1 (0.57) | L3MBTL1ATMPOLBMGAMGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8304581-B2 | Method of enantioselective addition to enones | NATIONAL TSING HUA UNIVERSITY (TW) | 2012-11-06 | — | — | US | disclosed |
| US-20110282101-A1 | METHOD OF ENANTIOSELECTIVE ADDITION TO ENONES | NATIONAL TSING HUA UNIVERSITY (TW) | 2011-11-17 | — | — | US | disclosed |
| US-6380392-B1 | COMPLEXES | THE PENN STATE RESEARCH FOUNDATION | 2002-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110282101-A1 | METHOD OF ENANTIOSELECTIVE ADDITION TO ENONES | CPNE4, ENY2, CYP3A4 | L3MBTL1 3225/4885ATM 4196/4885POLB 1520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.